DexCom, Inc. (DXCM) Financials

DXCM Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 6.6 billion 3.7 billion
Dec. 31, 2025 6.3 billion 3.6 billion
Sept. 30, 2025 7.5 billion 4.8 billion
June 30, 2025 7.3 billion 4.8 billion

DXCM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 449.0 million 43.3 million
Dec. 31, 2025 192.1 million 35.0 million
Sept. 30, 2025 579.4 million 45.1 million
June 30, 2025 208.9 million 45.3 million

DXCM Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 199.5 million
Dec. 31, 2025 267.3 million
Sept. 30, 2025 283.8 million
June 30, 2025 179.8 million

DXCM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.4 billion 1.2 billion 143.0 million
Dec. 31, 2025 2.0 billion 1.2 billion 148.8 million
Sept. 30, 2025 3.3 billion 1.2 billion 128.8 million
June 30, 2025 2.9 billion 1.2 billion 134.3 million

DXCM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 393.6 million
Dec. 31, 2025 398.9 million
Sept. 30, 2025 407.4 million
June 30, 2025 408.2 million

DXCM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 76.6 million 145.3 million 349.7 million -
Dec. 31, 2025 101.9 million 148.2 million 321.5 million -
Sept. 30, 2025 80.5 million 157.5 million 331.4 million -
June 30, 2025 94.1 million 148.2 million 328.0 million -

DXCM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.2 billion 441.6 million
Dec. 31, 2025 1.3 billion 466.9 million
Sept. 30, 2025 1.2 billion 461.9 million
June 30, 2025 1.2 billion 468.3 million

DXCM

Price: $74.77

52 week price:
54.11
89.98

Earnings Per Share: 2.33 USD

P/E Ratio: 25.91

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 3.0 million

Ebitda: 6.3 million

Market Capitalization: 28.1 billion

Links: